or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    SNGX F Soligenix, Inc. -4.27
    PPBT F Purple Biotech Ltd. 2.83
    MBIO F Mustang Bio, Inc. -0.53
    BNOX F Bionomics Limited -1.56
    CATX F Perspective Therapeutics, Inc. -51.38
    ADAP F Adaptimmune Therapeutics plc -4.23
    BDTX F Black Diamond Therapeutics, Inc. 0.00
    INMB F INmune Bio Inc. 4.39
    CRVO F CervoMed Inc. -0.62
    CRDF F Cardiff Oncology, Inc. -1.19
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Medicine Clinical Medicine Biotechnology Antineoplastic Drugs Biopharmaceutical Immune System Immunotherapy Radiation Solid Tumors Advanced Solid Tumors Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Checkpoint Inhibitor Chemotherapy Drugs Epidermal Growth Factor Receptor Immunotherapy Products Non Small Cell Lung Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 8.89
    MEDX F Horizon Kinetics Medical ETF 6.23
    PPH D Market Vectors Pharmaceutical ETF 5.89
    MVAL B SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    RDIV A RevenueShares Ultra Dividend Fund 5.27
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare MEDX to PPH Compare MVAL to RDIV Compare PPH to RDIV

        Cancer Treatment Stocks Recent News

        Date Stock Title
        Nov 21 CATX Perspective slips after Phase 1/2 trial data for radio pharma drug
        Nov 21 CATX Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
        Nov 19 CRDF Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
        Nov 18 BNOX Bionomics files for $100M mixed securities shelf
        Nov 16 ADAP Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 CATX Is Perspective Therapeutics (CATX) the Best Multibagger Stock to Buy Heading into 2025?
        Nov 15 CATX Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
        Nov 15 SNGX Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
        Nov 15 PPBT Purple Biotech GAAP EPS of -$0.39
        Nov 15 PPBT Purple Biotech Reports Third Quarter 2024 Financial Results
        Nov 15 ADAP Halozyme bids for Evotec; BeiGene gets a new name
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Antineoplastic Drugs Medicine Solid Tumors Melanoma Advanced Non Small Cell Lung Cancer Biotechnology Cancer Immunotherapy Cancer Therapies Epidermal Growth Factor Receptor Multiple Myeloma NSCLC Non Small Cell Lung Cancer Organic Chemistry Orphan Drug Protein Kinase Small Cell Lung Cancer Acid
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags